NewsRoom Articles - Page 50 of 226

FridayMay 24, 2024 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

PaxMedica has received an urgent plea from the Ministry of Health of Malawi for emergency access to IV suramin to prevent a potential humanitarian crisis due to dwindling supplies of essential drugs used to save lives in the region PaxMedica has previously concluded a Type B meeting with the FDA in preparation for the NDA submission, focusing on the use of PAX-101 in treating the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, transmitted by tsetse flies PaxMedica also aims to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide…

ThursdayMay 23, 2024 9:00 am

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

The HealthLynked platform provides secure and quick access for patient/doctor records communication, supporting all types of health related utilization, including telemedicine and remote student applications University health clinics often face challenges when transferring medical records – and this limits coordinated care for students The HealthLynked platform provides a streamlined approach to medical records access, allowing students to securely share their health information with relevant parties HealthLynked (OTCQB: HLYK) is a company on a mission to build a superior healthcare system through the efficient integration of patient histories, genetic data, and demographic insights, into a sophisticated AI-driven platform that streamlines patient care…

WednesdayMay 22, 2024 10:00 am

Study Identifies Genetic Link Between Parkinson’s, Inflammatory Bowel Disease

Inflammatory bowel disease is an umbrella term for two illnesses: ulcerative colitis and Crohn’s disease. These illnesses are characterized by chronic inflammation of the gastrointestinal tract. On the other hand, Parkinson’s disease is a neurodegenerative illness that affects an individual’s nervous system, causing issues with their movement by affecting body parts controlled by nerves. One analysis that involved 12 million participants determined that patients with inflammatory bowel disease have a heightened risk of being diagnosed with Parkinson’s, especially after age 65. Furthermore, the use of anti-inflammatory medications such as TNF-alpha inhibitors is linked to a decline in Parkinson’s risk. These…

TuesdayMay 21, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results

Clene presented clinical data at the 2024 American Academy of Neurology (“AAN”) Annual Meeting, demonstrating that long-term CNM-Au8® treatment resulted in significant evidence of repair and remyelination across multiple paraclinical endpoints Clene entered into a sub-award grant agreement with Columbia University under the previously announced National Institute of Health (“NIH”) Grant Clene announced the publication of “Protein Corona Composition of Gold Nanocatalysts” in the ACS Pharmacology & Translational Science journal Clene (NASDAQ: CLNN), a late-stage clinical biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), along with its wholly-owned subsidiary…

MondayMay 20, 2024 10:00 am

Study Offers Insights on Why Autoimmune Conditions Disproportionately Afflict Women

Autoimmune illnesses such as multiple sclerosis, rheumatoid arthritis, Crohn’s disease, lupus, scleroderma and psoriasis, usually cause an individual’s immune system to attack normal cells. Recent research has observed annual increases in overall incidence and prevalence of autoimmune illnesses. As of 2024, these figures stood at 19% and 12% respectively. Prior research has also found that a significant number of women, as compared to men, suffer from autoimmune illnesses. It is estimated that four out of every five patients with these illnesses are women. For the longest time, researchers could not explain this phenomenon, until now. New research has found an…

FridayMay 17, 2024 10:00 am

Robots Could Ease Order Fulfilment for eCommerce Companies

Small- to medium-sized e-commerce companies sometimes face challenges with fulfilling orders, especially when one considers the costs incurred when managing warehouses and fulfilment centers. To make it easier, most of these companies outsource the tasks. It is expected, however, that robots may soon take up these tasks as warehouse automation is adopted more by smaller companies. A recent report by Gartner forecasts that the warehouse automation industry will generate more that $21 billion in revenue globally this year. This is expected to hit $71 billion by 2032. Most of the revenue generated and growth observed in the industry can be…

WednesdayMay 15, 2024 10:00 am

New mRNA Vaccine Offers Hope Against Glioblastoma

Scientists from the University of Florida in America have designed a new vaccine for cancer that prompts the immune system to target glioblastoma. Glioblastoma is an aggressive type of cancer that forms in the spinal cord and/or brain. Roughly 19,000 people in the European Union are afflicted by this disease annually. The treatments used to manage glioblastoma haven’t changed since around 2000, with common treatments including radiotherapy, chemotherapy and surgical interventions. The average duration of survival for patients with glioblastoma is roughly 15 months. The new vaccine triggers the immune system to eliminate cells for cancers that are hard to…

TuesdayMay 14, 2024 9:00 am

HealthLynked Corp. (HLYK) Setting New Standard for Efficient Healthcare, Including Virtual Healthcare

HealthLynked leverages innovative cutting-edge technology and connectivity to make healthcare more efficient for patients and doctors The company’s HealthLynked Network, a comprehensive and sophisticated cloud-based healthcare platform, connects patients, healthcare providers, and medical facilities, providing centralized information access and communication Through its sophisticated platform, HealthLynked is changing how patients and medical professionals can, for example, interact with telehealth and telemedicine services The network facilitates real-time interactions between healthcare providers and patients, greatly improving the efficient delivery of healthcare information and services remotely through a user-facing app, securely transmitting needed patient data on demand HealthLynked (OTCQB: HLYK) offers cutting-edge technology and…

MondayMay 13, 2024 10:00 am

Hospice Remains Underserved by Medicare Advantage, Data Shows

While the Medicare Advantage space grows bigger, it is difficult for regulators and the medical industry to decide how best to integrate hospice into MA programs. This is a major concern because hospice care is the only segment of the healthcare sector that isn’t catered for in Medicare Advantage (MA). This is despite the fact that at least one-half of enrollees to MA programs require hospice care. A recent announcement that an experiment to test the inclusion of hospice in MA plans is coming to an early end due to limited insurer interest and operational challenges has raised several questions.…

FridayMay 10, 2024 10:00 am

Breakthrough MRI Tech is Poised to Revolutionize Early Disease Detection

A recent breakthrough in magnetic resonance imaging (MRI) technology could potentially revolutionize earl- disease detection and make it easier for physicians to diagnose medical conditions earlier than they currently do. Researchers from Northeastern University have developed a screening technique that produces MRI images of significantly better quality compared to conventional MRI scans, opening the door to the creation of more superior means of diagnosing diseases such as cancer. When bioengineer and physicist Codi Gharagouzloo enrolled in Northeastern University’s PhD program nearly 15 years ago, he dreamed of developing a cure for cancer and was convinced that nanoparticles could open up…